TNFα is required for cholestasis-induced liver fibrosis in the mouse
Erwin Gäbele(OTH Regensburg), Richard A. Rippe(University of North Carolina at Chapel Hill), Gavin E. Arteel(University of Pittsburgh), Claus Hellerbrand(Friedrich-Alexander-Universität Erlangen-Nürnberg), Ronald G. Thurman(University of North Carolina at Chapel Hill), Jürgen Schölmerich(University of Hohenheim), Matthias Froh(University of North Carolina at Chapel Hill), Takehiko Uesugi(University of North Carolina at Chapel Hill), David A. Brenner(Institute of Medical Microbiology and Hygiene)
Cited by 95
Related Papers
Liver fibrosis
|Journal of Clinical Investigation|2005|4.7k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Toll–Like Receptor 4 Mediates Inflammatory Signaling by Bacterial Lipopolysaccharide in Human Hepatic Stellate Cells
|Hepatology|2003|643
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
|Hepatology|2017|550
NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis
|Journal of Clinical Investigation|2003|544